Evidence map›Paper›PMID 35013634›Full record

ArticleAnnals of operations research2022

An extended robust mathematical model to project the course of COVID-19 epidemic in Iran.

Reza Lotfi, Kiana Kheiri, Ali Sadeghi, Erfan Babaee Tirkolaee

Abstract read
In one paragraph

Article in Annals of operations research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Computers & industrial engineering · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza LotfiDepartment of Industrial Engineering, Yazd University, Yazd, Iran.ORCID 0000-0001-5868-8467
Kiana KheiriDepartment of Mathematical Sciences, Shahid Beheshti University, Tehran, Iran.
Ali SadeghiDepartment of Industrial Engineering, Yazd University, Yazd, Iran.
Erfan Babaee TirkolaeeDepartment of Industrial Engineering, Istinye University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research develops a regression-based Robust Optimization (RO) approach to efficiently predict the number of patients with confirmed infection caused by the recent Coronavirus Disease (COVID-19). The main idea is to study the dynamics of the COVID-19 outbreak at the first stage and then provide efficient insights to estimate the necessary resources accordingly. The convex RO with Mean Absolute Deviation (MAD) objective function is utilized to project the course of COVID-19 epidemic in Iran. To validate the performance of the suggested model, a real-case study is investigated and compared to several well-known forecasting models including Simple Moving Average, Exponential Moving Average, Weighted Moving Average and Exponential Smoothing with Trend Adjustment models. Furthermore, the effect of parameter uncertainties is examined using a set of sensitivity analyses. The results demonstrate that by increasing the degree (coefficient) of regression up to 8, MAD value decreases to 1378.12, and consequently, the corresponding equation becomes more accurate. On the other hand, from the 8th degree onwards, MAD value follows an upward trend. Furthermore, by increasing the level of regression uncertainty, MAD value follows a downward trend to reach 1309.28 and the estimation accuracy of the model increases accordingly. Finally, our proposed model achieves the least MAD and the greatest correlation coefficient against the other models.

Indexed as

COVID-19 pandemicMean absolute deviationPredictionRegressionRobust optimization

Identifiers

PMID35013634
PMCPMC8732964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.